KMT2B and neoplasm: Treatment with MTA, a specific blocker of H3K4 methylation, abolished the KMT2B‐induced proliferation, migration and invasion of PDAC cells (p < .05, Figure 5B‒D), indicating that histone modification was involved in the pro‐tumour effects of KMT2B.